Lack of new antiinfective agents: Passing into the pre-antibiotic age?

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Background:

• Increasing antimicrobial resistance in pathogenic bacteria is a critical global health concern.
• The development of new antibiotics has significantly slowed, creating a gap in treatment options.
• Severe bacterial infections like sepsis and septic shock have high mortality rates, with conventional antibiotics increasingly failing.

Purpose of the Study:

• To outline the challenges posed by antimicrobial resistance and the lack of new antibiotic development.
• To present potential alternative strategies for combating severe bacterial infections and sepsis.

Main Methods:

• Review of current literature on antimicrobial resistance trends.
• Analysis of the impact of pharmaceutical industry withdrawal from anti-infective drug development.
• Exploration of alternative therapeutic approaches.

Main Results:

• Antimicrobial resistance is escalating, leading to treatment failures in severe infections.
• The pharmaceutical pipeline for new antibiotics is insufficient to address the growing threat.
• Existing treatments for sepsis and septic shock are becoming less effective.

Conclusions:

• Urgent development of novel antibiotics and alternative therapies is necessary.
• Addressing the challenge requires a multi-faceted approach involving research and policy.
• Failure to act will result in a significant global health crisis in the 21st century.